These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 11208907)
1. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. Mazzola JL; Sirover MA J Neurochem; 2001 Jan; 76(2):442-9. PubMed ID: 11208907 [TBL] [Abstract][Full Text] [Related]
2. Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts. Mazzola JL; Sirover MA Brain Res Mol Brain Res; 2002 Apr; 100(1-2):95-101. PubMed ID: 12008025 [TBL] [Abstract][Full Text] [Related]
3. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts. Mazzola JL; Sirover MA J Neurosci Res; 2003 Jan; 71(2):279-85. PubMed ID: 12503091 [TBL] [Abstract][Full Text] [Related]
4. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Mazzola JL; Sirover MA Neurotoxicology; 2002 Oct; 23(4-5):603-9. PubMed ID: 12428732 [TBL] [Abstract][Full Text] [Related]
5. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation. Gerszon J; Rodacka A Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002 [TBL] [Abstract][Full Text] [Related]
6. Aging of human glyceraldehyde-3-phosphate dehydrogenase is dependent on its subcellular localization. Mazzola JL; Sirover MA Biochim Biophys Acta; 2005 Mar; 1722(2):168-74. PubMed ID: 15716040 [TBL] [Abstract][Full Text] [Related]
7. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease. El Kadmiri N; Slassi I; El Moutawakil B; Nadifi S; Tadevosyan A; Hachem A; Soukri A Pathol Biol (Paris); 2014 Dec; 62(6):333-6. PubMed ID: 25246025 [TBL] [Abstract][Full Text] [Related]
9. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. Butterfield DA; Hardas SS; Lange ML J Alzheimers Dis; 2010; 20(2):369-93. PubMed ID: 20164570 [TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of human glyceraldehyde-3-phosphate dehydrogenase is independent of its glycolytic function. Mazzola JL; Sirover MA Biochim Biophys Acta; 2003 Jun; 1622(1):50-6. PubMed ID: 12829261 [TBL] [Abstract][Full Text] [Related]
11. Subcellular analysis of aberrant protein structure in age-related neurodegenerative disorders. Mazzola JL; Sirover MA J Neurosci Methods; 2004 Aug; 137(2):241-6. PubMed ID: 15262067 [TBL] [Abstract][Full Text] [Related]
12. [Properties and functional diversity of glyceraldehyde-3-phosphate dehydrogenase]. Rodacka A Postepy Hig Med Dosw (Online); 2013 Aug; 67():775-89. PubMed ID: 24018444 [TBL] [Abstract][Full Text] [Related]
13. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Sirover MA Biochim Biophys Acta; 1999 Jul; 1432(2):159-84. PubMed ID: 10407139 [TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of Glycolytic Enzymes PFKFB3 and GAPDH in the Modulation of Aβ and Neurodegeneration and Their Potential of Therapeutic Targets in Alzheimer's Disease. Ahmad I; Singh R; Pal S; Prajapati S; Sachan N; Laiq Y; Husain H Appl Biochem Biotechnol; 2023 Jul; 195(7):4673-4688. PubMed ID: 36692648 [TBL] [Abstract][Full Text] [Related]
15. Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders. Berry MD J Psychiatry Neurosci; 2004 Sep; 29(5):337-45. PubMed ID: 15486605 [TBL] [Abstract][Full Text] [Related]
16. Glyceraldehyde-3-phosphate dehydrogenase is involved in the pathogenesis of Alzheimer's disease. Schmalhausen EV; Medvedeva MV; Muronetz VI Arch Biochem Biophys; 2024 Aug; 758():110065. PubMed ID: 38906311 [TBL] [Abstract][Full Text] [Related]
17. Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease. Mikhaylova ER; Lazarev VF; Nikotina AD; Margulis BA; Guzhova IV J Neurochem; 2016 Mar; 136(5):1052-63. PubMed ID: 26662373 [TBL] [Abstract][Full Text] [Related]
18. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. Schulze H; Schuler A; Stüber D; Döbeli H; Langen H; Huber G J Neurochem; 1993 May; 60(5):1915-22. PubMed ID: 8473906 [TBL] [Abstract][Full Text] [Related]